phosphoserine has been researched along with sphingosine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellan, J; Chap, H; Gaigé, B; Grévy, JM; Gueguen, G; Klaébé, A; Pont, F; Rogalle, P; Simon, MF; Wilson, M | 1 |
Bokoch, GM; Mooney, AF; Reed, JC; Sanders, LC; Schürmann, A; Sells, MA; Wang, HG | 1 |
Clemens, JJ; Davis, MD; Lynch, KR; Macdonald, TL | 1 |
Danneberg, K; Hla, T; Jakobs, KH; Ktistakis, NT; Lichte, K; Liphardt, K; Meyer zu Heringdorf, D; Pitson, SM; ter Braak, M | 1 |
Klöckl, L; Schuchardt, M; Tölle, M; van der Giet, M; Wiedon, A; Zidek, W | 1 |
Aiba, A; Jona, M; Kassai, H; Kurano, M; Morimoto, Y; Nakao, K; Shimizu, T; Tsuneyama, K; Yatomi, Y | 1 |
Dokuni, R; Kamiryo, H; Katsurada, M; Kawa, Y; Kobayashi, K; Nagano, T; Nishimura, Y; Terashita, T; Umezawa, K; Yamamoto, M; Yasuda, Y; Yoshizaki, A | 1 |
Jing, X; Li, Y; Liu, B; Liu, Y; She, Q | 1 |
8 other study(ies) available for phosphoserine and sphingosine
Article | Year |
---|---|
Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Topics: Humans; Lysophospholipids; Palmitates; Phosphoserine; Platelet Aggregation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Sphingosine; Structure-Activity Relationship | 1999 |
p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis.
Topics: 14-3-3 Proteins; Animals; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Carrier Proteins; cdc42 GTP-Binding Protein; Cell Line; Cell Survival; Enzyme Activation; Interleukin-3; Mice; Mutation; p21-Activated Kinases; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Phosphoserine; Protein Binding; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins c-bcl-2; rho GTP-Binding Proteins; Signal Transduction; Sphingosine; Tyrosine 3-Monooxygenase | 2000 |
Sphingosine 1-phosphate analogs as receptor antagonists.
Topics: Calcium; Cell Line; Cell Membrane; Cell Movement; Dose-Response Relationship, Drug; Drug Design; Fingolimod Hydrochloride; Guanosine Triphosphate; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Lipids; Lymphocytes; Lysophospholipids; Models, Chemical; Phosphoserine; Propylene Glycols; Protein Binding; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Structure-Activity Relationship; Transfection | 2005 |
Galpha(q)-mediated plasma membrane translocation of sphingosine kinase-1 and cross-activation of S1P receptors.
Topics: Animals; Cell Membrane; Diglycerides; Endocytosis; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Mice; Phospholipase D; Phosphoserine; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase C; Protein Transport; Receptor, Muscarinic M3; Receptors, Lysosphingolipid; Sphingosine | 2009 |
Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.
Topics: Anilides; beta-Alanine; Endothelial Cells; Enzyme Activation; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Organophosphates; Organophosphonates; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; RNA, Small Interfering; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiazolidines; Thiophenes | 2016 |
Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury.
Topics: Alanine Transaminase; Animals; Apolipoproteins M; Clustered Regularly Interspaced Short Palindromic Repeats; Creatinine; Disease Models, Animal; Disseminated Intravascular Coagulation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipopolysaccharides; Lipoproteins, HDL; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; Phosphoserine; Receptors, Lysosphingolipid; Sepsis; Sphingosine | 2018 |
Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchi; Cell Line; Chemokine CCL20; Disease Models, Animal; Eosinophilia; Epithelial Cells; Female; Gene Expression; Gene Knockdown Techniques; Humans; Lysophospholipids; Mice; Mice, Inbred BALB C; Phosphoserine; Receptors, Adrenergic, beta-2; Receptors, Lysosphingolipid; Receptors, Prostaglandin E, EP4 Subtype; Sphingosine; Sphingosine-1-Phosphate Receptors | 2018 |
Sphingosine 1-phosphate induces epicardial progenitor cell differentiation into smooth muscle-like cells.
Topics: Actins; Animals; Cell Differentiation; Cells, Cultured; Gene Expression Regulation; Lysophospholipids; Mice; Mice, Inbred C57BL; Mouse Embryonic Stem Cells; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pericardium; Phosphoserine; Pyrazoles; Pyridines; Receptors, Lysosphingolipid; Sphingosine | 2019 |